These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16797244)

  • 1. Liver diseases in the hemochromatosis and iron overload screening study.
    Adams PC; Passmore L; Chakrabarti S; Reboussin DM; Acton RT; Barton JC; McLaren GD; Eckfeldt JH; Dawkins FW; Gordeuk VR; Harris EL; Leiendecker-Foster C; Gossman E; Sholinsky P;
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):918-23; quiz 807. PubMed ID: 16797244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
    Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
    Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
    Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
    Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
    Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
    Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
    McLaren CE; Barton JC; Eckfeldt JH; McLaren GD; Acton RT; Adams PC; Henkin LF; Gordeuk VR; Vulpe CD; Harris EL; Harrison BW; Reiss JA; Snively BM
    Am J Hematol; 2010 Feb; 85(2):101-5. PubMed ID: 20095037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
    Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
    Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
    Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
    McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
    Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.
    Gordeuk VR; Reboussin DM; McLaren CE; Barton JC; Acton RT; McLaren GD; Harris EL; Reiss JA; Adams PC; Speechley M; Phatak PD; Sholinsky P; Eckfeldt JH; Chen WP; Passmore L; Dawkins FW
    Am J Hematol; 2008 Aug; 83(8):618-26. PubMed ID: 18429050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
    Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH
    Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.
    Gurrin LC; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
    Gastroenterology; 2008 Dec; 135(6):1945-52. PubMed ID: 18848943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.